555 LONG WHARF DRIVE, NEW HAVEN, CT
Material disclosure
BioXcel Therapeutics Enters $1.25M Loan Agreement Amendment
BioXcel Therapeutics Enters Thirteenth Amendment to Credit Agreement
BioXcel Therapeutics Enters Twelfth Amendment to Credit Agreement
News, Material Contracts
Tenth Amendment to Credit Agreement with Oaktree Fund Administration
Provides Business Update and Reports First Quarter 2026 Financial Results
Q2
Q1
Q3
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership
Submission Upload
Correspondence